| This week's sponsor is Ajinomoto Bio-Pharma Services. | |  | |
Today's Rundown Featured Story | | | Tuesday, January 22, 2019 Just a few months after getting the all-clear to start its first CRISPR trial and bagging a nice check from Allergan in the process, Editas’ chief executive and president Katrine Bosley is hitting the exit. |
|
|
| This week's sponsor is Sprout BioVentures. | |  | Announcing the Golden Sprout Competition
High-potential start-ups are encouraged to apply for the Golden Sprout Award. Winners receive 6 months of chemistry support (2 FTEs) at no cost. Application period closes February 28, 2019. Click here for more information. |
Top Stories Tuesday, January 22, 2019 The FDA has placed a clinical hold on the IND for Translate Bio’s mRNA treatment for ornithine transcarbamylase deficiency, a genetic disease that causes too much ammonia to build up in the blood. Tuesday, January 22, 2019 Aurinia Pharmaceuticals has presented a mixed bag of midphase data on its challenger to Allergan’s blockbuster dry eye drug Restasis. The challenger, VOS, failed to better the tolerability of Restasis but delivered superior efficacy on secondary endpoints, suggesting it may have an unexpected edge over its rival. Tuesday, January 22, 2019 Gamida Cell is teaming up with Be The Match BioTherapies, a service-focused subsidiary of the National Marrow Donor Program, to help support the late-phase development of its cell therapy that aims to offer an alternative source of universal bone marrow transplant material for patients with blood cancers. Tuesday, January 22, 2019 A phase 1b study of a nonopioid, nerve-ablating painkiller from Sorrento Therapeutics showed rapid relief of osteoarthritic knee pain that lasted for nearly three months at its lowest dose, prompting the company to begin planning pivotal studies for this year. Tuesday, January 22, 2019 Fresh from reporting clinical data at ASH, Beijing biotech Immunochina has raised $20 million in a third-round financing to speed up its CAR-T development programs. Tuesday, January 22, 2019 Wren Therapeutics has raised £18 million ($23 million). The British biotech will use the series A round to advance its research into drugs to treat protein-misfolding diseases such as Alzheimer’s. Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Sponsored by: AlphaSense It’s never been more challenging to stay on top of competitive factors impacting your industry. Discover how AI can help competitive teams achieve more proactive market intelligence. Sponsored by: Reprints Desk, Inc. Go from Search to Full-Text Scientific Papers in a Single Click! Sponsored by: Blue Latitude Health This white paper consists of original data and expert interviews. Download it today for exclusive tools, tips and analysis on achieving launch excellence in challenging pharma markets. Sponsored by: Outer Edge Technology With FDA approval imminent, start-up Life Sciences company partners with an industry focused MSP to design and manage its regulated cloud-based infrastructure to speed time to market. Sponsored by: DeciBio Consulting With the liquid biopsy market maturing and >80 companies still competing with liquid biopsy offerings, it is crucial for investors to be able to cut through the noise and identify the winners. Presented by: Veeva Share your thoughts on the life sciences industry's progress in improving study execution. Presented by: Aprecia Get ahead of looming challenges in the market that include both generic products and new branded drugs. Sponsored by: Oracle Health Sciences New infographic shows trends in clinical development and the impact on randomization and trial supply management technology (RTSM). Sponsored by: Veeva Reduce the effort to create submissions and track registrations with a move to unified RIM. Watch the on-demand webinar. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. | 
